Literature DB >> 25550384

Precision medicine meets public health: population screening for BRCA1 and BRCA2.

Ephrat Levy-Lahad1, Amnon Lahad2, Mary-Claire King2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25550384     DOI: 10.1093/jnci/dju420

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  25 in total

1.  [Universal genetic testing to combat underdiagnosis of hereditary breast cancer].

Authors:  Marciana Nona Duma; Andrea Wittig
Journal:  Strahlenther Onkol       Date:  2019-06       Impact factor: 3.621

2.  Diversity in the Era of Precision Medicine - From Bench to Bedside Implementation.

Authors:  Abdullah Mamun; Nana Y Nsiah; Meenakshi Srinivasan; Ayyappa Chaturvedula; Riyaz Basha; Deanna Cross; Harlan P Jones; Karabi Nandy; Jamboor K Vishwanatha
Journal:  Ethn Dis       Date:  2019-07-18       Impact factor: 1.847

3.  BRCA testing in unaffected young women in the United States, 2006-2017.

Authors:  Fangjian Guo; Matthew Scholl; Erika L Fuchs; Abbey B Berenson; Yong-Fang Kuo
Journal:  Cancer       Date:  2019-09-30       Impact factor: 6.860

4.  Community attitudes towards a Jewish community BRCA1/2 testing program.

Authors:  Nicole Cousens; Rajneesh Kaur; Bettina Meiser; Lesley Andrews
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

5.  Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.

Authors:  Anita Y Kinney; Laurie E Steffen; Barbara H Brumbach; Wendy Kohlmann; Ruofei Du; Ji-Hyun Lee; Amanda Gammon; Karin Butler; Saundra S Buys; Antoinette M Stroup; Rebecca A Campo; Kristina G Flores; Jeanne S Mandelblatt; Marc D Schwartz
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

6.  The future of clinical cancer genomics.

Authors:  Kenneth Offit
Journal:  Semin Oncol       Date:  2016-10-18       Impact factor: 4.929

7.  A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.

Authors:  Ana F Best; Margaret A Tucker; Megan N Frone; Mark H Greene; June A Peters; Hormuzd A Katki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-28       Impact factor: 4.254

Review 8.  Personalised medicine and population health: breast and ovarian cancer.

Authors:  Steven A Narod
Journal:  Hum Genet       Date:  2018-10-17       Impact factor: 4.132

Review 9.  A pediatric perspective on genomics and prevention in the twenty-first century.

Authors:  Bimal P Chaudhari; Kandamurugu Manickam; Kim L McBride
Journal:  Pediatr Res       Date:  2019-10-02       Impact factor: 3.756

Review 10.  Cancer genetics, precision prevention and a call to action.

Authors:  Clare Turnbull; Amit Sud; Richard S Houlston
Journal:  Nat Genet       Date:  2018-08-29       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.